Skip to main content

Full Schedule

Full Schedule

  • Wednesday, June 21, 2023
  • 8:00 AM – 8:15 AM
    Welcome
  • 8:15 AM – 9:00 AM
    1 - Session 1: Choosing among Options for the Initial Therapy of Aggressive Lymphoma
  • 9:00 AM – 9:15 AM
    Break
  • 9:15 AM – 10:00 AM
    Session 2: Quality of Life and Survivorship in Lymphoma Patient

    Presenter: Carrie Thompson, MD, MS – Mayo Clinic

  • 10:00 AM – 10:15 AM
    Break
  • 10:15 AM – 11:15 AM
    Learn About a Different Approach to BTK Inhibition PP-PT-US-0216
  • 11:15 AM – 11:30 AM
    Break
  • 11:30 AM – 12:05 PM
    4 - Session 3: How Do We Choose among non-CAR-T Options for Patients with Recurrent Aggressive Lymphoma

    Presenter: Jennifer Amengual, MD – Columbia University

  • 12:05 PM – 12:15 PM
    Live Q&A

    Moderator: John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian

    Speaker: Jennifer Amengual, MD – Columbia University

  • 12:15 PM – 12:30 PM
    Break
  • 12:30 PM – 1:05 PM
    Session 4: Arguments For and Against ‘Watch and Wait’ in Follicular Lymphoma
  • 1:05 PM – 1:15 PM
    Live Q&A
  • 1:15 PM – 1:30 PM
    Break
  • 1:30 PM – 2:05 PM
    5 - Session 5: Antibody Drug Conjugates – Where and When to Use Them in Hodgkin Lymphoma
  • 2:05 PM – 2:15 PM
    Live Q&A
  • 2:15 PM – 2:30 PM
    Break
  • 2:30 PM – 3:05 PM
    Session 6: What is the Value of Surveillance Imaging in Aggressive Lymphoma and How Can We Tailor Follow Up?

    Presenter: Peter Martin, MD – NewYork Presbyterian Hospital, Weill Cornell Medicine

  • 3:05 PM – 3:15 PM
    Live Q&A

    Moderator: John P. Leonard, MD – Weill Cornell Medicine/New York Presbyterian

    Speaker: Peter Martin, MD – NewYork Presbyterian Hospital, Weill Cornell Medicine

  • 3:15 PM – 3:30 PM
    Break
  • 3:30 PM – 3:47 PM
    7 - Session 7: Debate - CNS Prophylaxis in Aggressive Lymphoma - Aggressive
  • 3:47 PM – 4:05 PM
    7 - Session 7: Debate - CNS Prophylaxis in Aggressive Lymphoma - Futile
  • 4:05 PM – 4:15 PM
    7 - Session 7: Debate - CNS Prophylaxis in Aggressive Lymphoma